04:28 AM EDT, 09/25/2025 (MT Newswires) -- Moderna ( MRNA ) said late Wednesday it has opened a manufacturing and research and development facility at the Harwell Science and Innovation Campus in Oxfordshire, UK.

The new facility, named Moderna Innovation and Technology Center, will produce mRNA respiratory vaccines for the UK market and will support research into the potential of mRNA science in other areas of medicine, the company said.

The site has an annual production capacity of up to 100 million vaccine doses, expandable to 250 million doses in the event of a pandemic, Moderna ( MRNA ) said.